Late Breaking Clinical Trials and First Report Investigations I
最新揭晓临床试验和首次公布研究(一)

1:30 PM-3:15 PM Friday, March 29, 2019

2019年03月29日 星期五   1:30 PM-3:15 PM

Function Hall A, Level 1

一层多功能A厅

Moderator 主持人 Gregg W. Stone, Steven R. Bailey
Discussant 讨论者 Alexandra J. Lansky, Ehtisham Mahmud, Marie-Angèle Morel, Tullio Palmerini, Duane S. Pinto, Alan C. Yeung

1:30 PM-

DESSOLVE C: A Randomized Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease (LB-0014)
DESSOLVE C:比较两种生物可降解聚合物涂层西罗莫司洗脱支架治疗冠心病的随机试验(LB-0014)
Bin Wang 王斌

1:40 PM-

Discussion
讨论

1:45 PM-

A Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for Treatment of Unprotected Left Main Bifurcation Lesion (LB-0015)
评价斑块主动转移和“即兴”T支架术治疗无保护左主干分叉病变有效性和安全性的随机试验(LB-0015)
Lixia Yang 杨丽霞

1:55 PM-

Discussion
讨论

2:00 PM-

An Objective Performance Criterion Study Evaluating the Safety and Efficacy of TaurusOne TAVR System for Treatment of Severe Aortic Stenosis: 30-Day Results (LB-0004)
评估TaurusOne经导管主动脉瓣置换系统治疗严重主动脉瓣狭窄的安全性和有效性单组目标值研究:30天结果(LB-0004)
Runlin Gao 高润霖

2:10 PM-

Discussion
讨论

2:15 PM-

A Randomized Trial Comparing Xinsorb Sirolimus-Eluting Bioresorbable Scaffold with Tivoli Sirolimus-Eluting Stent in Patients with Coronary Artery Disease: 3-Year Clinical Outcomes (LB-0007)
一项在冠心病患者中比较Xinsorb西罗莫司洗脱生物可吸收支架和Tivoli西罗莫司洗脱支架的随机试验:三年临床疗效(LB-0007)
Junbo Ge 葛均波

2:25 PM-

Discussion
讨论

2:30 PM-

A Randomized Trial Comparing NeoVas Sirolimus-Eluting Bioresorbable Scaffold with Xience Everolimus-Eluting Stent in Patients with Coronary Artery Disease: 3-Year Clinical Outcomes (LB-0009)
一项在冠心病患者中比较NeoVas西罗莫司洗脱生物可吸收支架和Xience依维莫司洗脱支架的随机试验:三年临床疗效(LB-0009)
Yaling Han 韩雅玲

2:40 PM-

Discussion
讨论

2:45 PM-

Safety and Efficacy of the NeoVas Sirolimus-Eluting Bioresorbable Scaffold for Treatment of De Novo Coronary Artery Disease: 2-Year Results of the NeoVas OPC Study (LB-0010)
NeoVas西罗莫司洗脱生物可吸收支架治疗原发冠脉病变的安全性和有效性:NeoVas单组目标值研究两年结果(LB-0010)
Guosheng Fu 傅国胜

2:55 PM-

Discussion
讨论

3:00 PM-

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Scaffold in Patients with Coronary Artery Disease (FUTURE-I): 3 -Year Clinical and Imaging Outcomes (LB-0005)
Firesorb西罗莫司靶向洗脱生物可吸收支架治疗冠心病的首次人体研究(FUTURE-I):三年临床和影像学结果(LB-0005)
Bo Xu 徐波

3:10 PM-

Discussion
讨论

3:15 PM-

Adjourn
休会